RxDoctor Payments Data

Yat Choi Kwong

Allergy & Immunology · Los Angeles, CANPI 1649315698

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $174,682 of the $180,893 with a category attached, or 96.6%. Phadia US Inc. accounts for 97.8% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $97,413 and has fallen 98.9% since, to $1,028 in 2025. Among allergy & immunology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$180,893in general payments, 2019–2025

Across 195 payments — averaging $927.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phadia US Inc.$177K
  • GSK$1K
  • Novartis$525
  • CSL Behring$287
  • Biocryst US Sales Co., LLC$256
  • Blueprint Medicines Corporation$191
  • plus $1K from 16 others

What the payments were for

  • Consulting fees$174,68297%
  • Travel & lodging$1,5341%
  • Food & beverage$4,6093%
  • Education$690%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$180,893 in reported general payments places this provider in the 95th percentile of 426 allergy & immunology providers in California.

See all allergy & immunology providers in California

Other allergy & immunology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →